Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DEGS1 | O15121 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.69 |
| ▸ | NAMPT | P43490 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | GAA | P10253 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.69 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | NPC1 | O15118 | 3/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.60 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14014144 | 1.00 | DEGS1 (0.76) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA | |
| SCHEMBL26373212 | 0.94 | DEGS1 (0.67) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA | |
| SCHEMBL26373196 | 0.92 | ALDH1A1 (0.72) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA | |
| SCHEMBL15706299 | 0.89 | DEGS1 (0.82) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA | |
| SCHEMBL20284023 | 0.87 | DEGS1 (0.74) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA | |
| SCHEMBL21522275 | 0.86 | DEGS1 (1.00) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA | |
| SCHEMBL20284448 | 0.86 | DEGS1 (1.00) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA | |
| SCHEMBL15560342 | 0.85 | DEGS1 (0.76) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA | |
| SCHEMBL20707736 | 0.85 | DEGS1 (0.76) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA | |
| SCHEMBL16845366 | 0.85 | DEGS1 (0.76) | DEGS1ALDH1A1SMN1; SMN2NAMPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011085351-A2 | METHOD OF TREATING KCNQ RELATED DISORDERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-07-14 | — | — | WO | claimed |
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| EP-4580679-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS | Biohaven Therapeutics Ltd. (VG) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024054807-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND TDP-43 MODULATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024050389-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-07 | — | — | WO | disclosed |
| WO-2011085351-A2 | METHOD OF TREATING KCNQ RELATED DISORDERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-07-14 | — | — | WO | disclosed |